TESTI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 19.600
AS - Asia 1.878
EU - Europa 1.784
SA - Sud America 258
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 28
OC - Oceania 6
Totale 23.692
Nazione #
US - Stati Uniti d'America 19.528
SG - Singapore 942
CN - Cina 382
DE - Germania 306
RU - Federazione Russa 283
IT - Italia 273
UA - Ucraina 239
BR - Brasile 217
IE - Irlanda 158
VN - Vietnam 136
GB - Regno Unito 123
HK - Hong Kong 110
FI - Finlandia 107
SE - Svezia 100
BD - Bangladesh 90
FR - Francia 59
KR - Corea 54
JP - Giappone 49
CA - Canada 44
PL - Polonia 33
IN - India 29
BE - Belgio 26
NL - Olanda 24
MX - Messico 17
AR - Argentina 12
IQ - Iraq 12
CZ - Repubblica Ceca 11
KG - Kirghizistan 11
ID - Indonesia 10
ZA - Sudafrica 9
AT - Austria 8
LT - Lituania 8
CL - Cile 7
EC - Ecuador 7
MY - Malesia 6
PY - Paraguay 6
TR - Turchia 6
CO - Colombia 5
ES - Italia 5
EU - Europa 5
NP - Nepal 5
PK - Pakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AU - Australia 4
IL - Israele 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
GR - Grecia 3
KZ - Kazakistan 3
NI - Nicaragua 3
NO - Norvegia 3
PH - Filippine 3
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
KE - Kenya 2
LY - Libia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 23.560
Città #
Woodbridge 5.306
Wilmington 4.827
Houston 4.313
Fairfield 612
Ann Arbor 558
Singapore 458
Chandler 443
Ashburn 419
Seattle 247
San Jose 234
Jacksonville 225
Cambridge 194
New York 153
Dearborn 147
Dublin 141
Rome 129
Medford 119
Beijing 117
Hong Kong 108
Council Bluffs 77
Los Angeles 73
The Dalles 71
Santa Clara 65
Munich 58
Lawrence 56
Chicago 49
Dallas 46
Tokyo 45
Guangzhou 43
Mülheim 42
Ho Chi Minh City 41
Buffalo 38
Helsinki 36
Moscow 36
Menlo Park 33
Milan 32
Hanoi 30
São Paulo 29
Brussels 26
Turku 21
San Diego 20
Orem 18
Boardman 17
Brooklyn 16
London 16
Palo Alto 16
Warsaw 16
Chennai 15
Falls Church 15
Mountain View 15
Nuremberg 15
Lauterbourg 14
Montreal 14
Atlanta 13
Denver 12
Hefei 12
Kraków 12
Redwood City 12
Toronto 11
Amsterdam 10
Columbus 10
Frankfurt am Main 10
San Mateo 10
Brno 9
Kunming 9
Norwalk 9
Poplar 9
Nanjing 8
Salt Lake City 8
San Francisco 8
Stockholm 8
University Park 8
Belo Horizonte 7
Haiphong 7
Phoenix 7
Redondo Beach 7
Rio de Janeiro 7
Shenyang 7
Vienna 7
Da Nang 6
Detroit 6
Elk Grove Village 6
Johannesburg 6
Manchester 6
Miami 6
Nanchang 6
Querétaro 6
Wuhan 6
Calgary 5
Curitiba 5
Jinan 5
Kansas City 5
Mexico City 5
Saint Petersburg 5
Tampa 5
Tashkent 5
Ankara 4
Asunción 4
Brasília 4
Charlotte 4
Totale 20.251
Nome #
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 615
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia 547
Analysis of intracellular distribution and apoptosis involvement of the Ufd1l gene product by over-expression studies 509
A caspaselike activity is triggered by LPS and is required for survival of human dendritic cells 508
GD3 ganglioside as an intracellular mediator of apoptosis 508
C. elegans as a model for Friedreich Ataxia 507
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 502
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia 496
GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion 493
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin 491
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells 491
Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis 483
c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization 483
A pool of extramitochondrial frataxin that promotes cell survival 481
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression 473
Caspase-dependent cleavage of c-Abl contributes to apoptosis 468
Calnexin suppresses GD3 synthase-induced apoptosis 464
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 462
Frataxin participates to the hypoxia-induced response in tumors 459
Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans 457
Long-lived C. elegans Mitochondrial mutants as a model for human mitochondrial-associated diseases 450
Differential regulation of apoptotic cell death in senescent human cells 450
Acetylation suppresses the proapoptotic activity of GD3 ganglioside 449
Intracellular mediators of programmed cell death initiated at the cell surface receptor Fas 448
A role for p53 in mitochondrial stress response control of longevity in C. elegans. 448
TRANSCRIPTIONAL REGULATION OF INTERLEUKIN-2 GENE-EXPRESSION BY CD69-GENERATED SIGNALS 447
UVB-induced apoptosis of human dendritic cells: contribution by caspase-dependent and caspase-independent pathways 445
Mitochondrial lipids as apoptosis regulators 443
9-O-acetyl GD3 protects tumor cells from apoptosis 442
Differential regulation of apoptotic cell death in senescent human cells 441
Mitochondria as sensors of sphingolipids 439
GD3 in cellular ageing and apoptosis 438
Lipid signaling in CD95-mediated apoptosis 437
Lipid and glycolipid mediators in CD95-induced apoptotic signaling. 427
In vivo maturation of human frataxin 427
Ceramide catabolism critically controls survival of human dendritic cells 427
Is it cytotoxicity or apoptosis which causes cell death in autoimmunity? 418
p53/CEP-1 increases or decreases lifespan, depending on level of mitochondrial bioenergetic stress 417
GD3 ganglioside and apoptosis 406
Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans 405
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function 400
Src inhibitors modulate frataxin protein levels 398
Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis 384
The ganglioside GD3 as the greek goddess Hecate: Several faces turned towards as many directions 383
Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C 374
ATM Kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells 371
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model 340
Frataxin deficiency in Friedreich’s ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival 327
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia 325
Biophysical characterisation of the recombinant human frataxin precursor 308
SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia 245
An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease 232
Analyzing the effects of a G137V mutation in the FXN gene 224
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients 191
Safety and efficacy of interferon γ in friedreich's ataxia 124
Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1 119
Interferon gamma enhances cytoprotective pathways via Nrf2 and MnSOD induction in Friedreich’s ataxia cells 96
Sensitivity of neuroimaging indicators in monitoring the effects of interferon gamma treatment in Friedreich's Ataxia 87
Drug Repositioning in Friedreich Ataxia 83
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients 54
Lipid signaling in CD95-mediated apoptosis 26
Totale 23.692
Categoria #
all - tutte 52.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 26 22 24 32 97 16 21 56 67 18 192
2022/2023917 105 100 80 124 72 164 44 52 89 7 60 20
2023/2024303 41 10 10 5 24 116 11 14 3 4 12 53
2024/20251.449 102 291 130 72 53 63 60 100 130 125 170 153
2025/20262.528 183 133 249 326 299 79 273 314 240 206 112 114
2026/2027185 108 77 0 0 0 0 0 0 0 0 0 0
Totale 23.692